Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 to 75 years who have been diagnosed with a gastric GIST (a type of stomach tumour) and have chosen to have it removed using an endoscopic procedure (a procedure done through the mouth using a flexible camera)
- People who have a growth found beneath the inner lining of the stomach, detected during a camera examination of the upper digestive tract
- People whose ultrasound scan (done via endoscopy) and CT scan with contrast dye suggest the tumour is growing from the deep muscle layer of the stomach wall, measures at least 1.0 cm and no more than 3.5 cm across
- People whose tumour does not show concerning features such as irregular edges, spread into nearby organs, or an unusually high blood supply
- People whose tumour location and appearance are assessed by an expert specialist as suitable for either of the two endoscopic removal techniques used in this trial
- People who have had a tissue sample taken from the tumour confirming it is a GIST (this is optional, based on guideline recommendations)
Who may not be able to join:
- People whose tumour is considered unsuitable for endoscopic removal due to its position, shape, or other concerns
- People who have more than one tumour
- People who are unable or unwilling to give their consent to take part
- People who have previously had surgery on the oesophagus (food pipe) or stomach
- People with significant heart or lung conditions that may make it unsafe to have a general anaesthetic, including those rated at a certain level of anaesthetic risk (confirm with trial site)
- Women who are pregnant, planning to become pregnant, or currently breastfeeding
- People with blood clotting problems that cannot be corrected, specifically certain abnormal blood test results indicating increased bleeding risk (confirm with trial site)
- People currently taking two blood-thinning or anti-clotting medications at the same time, including warfarin, heparin, or similar medicines
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hon Chi Yip, Chinese University of Hong Kong
Phone: +852 3505 2956
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete R0 resection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.